Loại tài liệu:    Chỉ tìm trong: 
111-120 trong số 155 kết quả
Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
Tác giả: Shi-Jia Liu, Xiao Zhang, Dong-Xu Wang, Yu-Chuan Yan, Tao Li, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Zhao-Ru Dong
Xuất bản: Germany: Journal of cancer research and clinical oncology , 2025
Bộ sưu tập: NCBI
ddc: 
 
Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis
Tác giả: Chuyu Wang, Ying Zhao, Chunyan Zhang, Wenjing Yang, Hao Wang, Wei Guo, Beili Wang, Yingfei Peng, Wei Chen, Jie Zhu, Chenzheng Gu, Ran Huo, Lin Ding, Yu Liu, Te Liu
Xuất bản: Germany: Phytomedicine : international journal of phytotherapy and phytopharmacology , 2025
Bộ sưu tập: NCBI
ddc: 
 
Elevated platelet distribution width and diabetes may serve as preoperative predictors of microvascular invasion in primary hepatocellular carcinoma
Tác giả: Ling Wang, Liu Jun, Jia Jian'an, Rao Chunmei, Jiang Yuhuan, Liu Peng, Li Huiming
Xuất bản: Germany: Journal of cancer research and clinical oncology , 2025
Bộ sưu tập: NCBI
ddc: 
 
Metabolism profiles of tannins in Phyllanthus emblica L. and its immunotherapeutic potential against hepatocellular carcinoma by re-educating tumor microenvironment
Tác giả: Zihao Chang, Zhaohui Wang, Lanzhen Zhang, Yinxin Chen, Yuqi Liu, Ye Gao, Yitong Cui, Le Wang, Yue Liu, Ruiyang Cheng, Runping Liu
Xuất bản: Germany: Phytomedicine : international journal of phytotherapy and phytopharmacology , 2025
Bộ sưu tập: NCBI
ddc: 
 
Response to "Comment on sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma"
Tác giả: Pei-Jui Luo, Chih-Horng Wu
Xuất bản: Singapore: Journal of the Formosan Medical Association = Taiwan yi zhi , 2025
Bộ sưu tập: NCBI
ddc: 
 
Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma"
Tác giả: Erkan Topkan
Xuất bản: Singapore: Journal of the Formosan Medical Association = Taiwan yi zhi , 2025
Bộ sưu tập: NCBI
ddc: 
 
Dynamic Prediction of the Risk of Hepatocellular Carcinoma After DAA Treatment for Hepatitis C Patients
Tác giả: Xinyan Ma, Lili Huang, Meijie Yu, Rui Dong, Yifan Wang, Hongbo Chen, Rongbin Yu, Peng Huang, Jie Wang
Xuất bản: United States: Cancer control : journal of the Moffitt Cancer Center , 2025
Bộ sưu tập: NCBI
ddc: 
 
Dynamic Prediction of the Risk of Hepatocellular Carcinoma After DAA Treatment for Hepatitis C Patients
Tác giả: Xinyan Ma, Lili Huang, Meijie Yu, Rui Dong, Yifan Wang, Hongbo Chen, Rongbin Yu, Peng Huang, Jie Wang
Xuất bản: United States: Cancer control : journal of the Moffitt Cancer Center , 2025
Bộ sưu tập: NCBI
ddc: 
 
Blood pressure elevations post-lenvatinib treatment in hepatocellular carcinoma: a potential marker for better prognosis
Tác giả: Keisuke Shibata, Yuichi Akasaki, Akihiro Tokushige, Mina Nitta, Shin Kawasoe, Takuro Kubozono, Kohei Oda, Kotaro Kumagai, Seiichi Mawatari, Mitsuru Ohishi
Xuất bản: England: Hypertension research : official journal of the Japanese Society of Hypertension , 2025
Bộ sưu tập: NCBI
ddc: 
 
Ablative margin assessment for recurrence prediction in patients with hepatocellular carcinoma receiving radiofrequency ablation
Tác giả: Geeng-Jia Hu, Quan-Yin Zheng, Feng-Guang Tsai, Chiueng-Fang Wu, Yi-Cheng Hsiao, Chih-Kai Chang, Po-Chin Liang, Chih-Horng Wu
Xuất bản: Singapore: Journal of the Formosan Medical Association = Taiwan yi zhi , 2025
Bộ sưu tập: NCBI
ddc: 
 

Truy cập nhanh danh mục